Skip to main content
Signal8

Dexter Susan

SEC insider (Form 3/4/5 filer). CIK 0001806764. Chief Technical Officer at Sonnet BioTherapeutics Holdings, Inc. (SONN). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in PRINCETON,, NJ.

Companies Dexter Susan has filed insider reports for

  • Sonnet BioTherapeutics Holdings, Inc. (SONN): Officer, Chief Technical Officer
Dexter Susan profile photo

Dexter Susan

CIK: 0001806764

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sonnet BioTherapeutics Holdings, Inc. logo
SONN

Sonnet BioTherapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    9.6K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 11, 2025
    Award
    Direct
    8K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 11, 2023
    Award
    Direct
    1.5K shares-

1-3 of 3